Posts Tagged: glaxosmithkline


State Department, Universities Blast UN Attack on Patents

If the UN Secretary General and the members of his "High Level Panel on Access to Medicines" thought the State Department was bluffing when it warned against …
By Joseph Allen
3 years ago 3

FDA approval of Teflaro puts Allergan’s portfolio of anti-infectives into focus

Treatments for infectious diseases is one area where Allergan is looking to buoy its fortunes in the coming years. The first quarter of 2016 was a strong one …
By Steve Brachmann
4 years ago 0

Biotech and Pharma Update: January 2014

Kava Plant May Prevent Cigarette Smoke-induced Lung Cancer *** Conditional Approval for Treatment of T-cell Lymphoma in Dogs *** All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C Genotype 1 *** …
By Gene Quinn
6 years ago 1

Biotech and Pharma Update: News for December 2013

What follows below is a review of some of the biotech and pharma news stories that caught my attention during the month of December 2013. Fitch Puts Negative …
By Gene Quinn
6 years ago 0

Pharma Scandals: Bribery, Insider Trading and Paula Deen

The summer may be in full swing, but the torrent pace of news and interesting developments has not subsided at all. Hot days simply yield hot stories. …
By Ed Silverman
7 years ago 0

Ranbaxy Fined, J&J Tylenol Scandal, Bayer Sued Over Vitamins

Once again, a plethora of interesting events has occurred since the last time we stopped by. What was the biggest headline? That decision may be up for …
By Ed Silverman
7 years ago 0

Pharma Law and Business: A Month Roundup for February 2013

The FDA decided not to pursue a re-hearing before a federal appeals court that recently ruled the federal government could not prosecute a sales rep who promoted …
By Ed Silverman
7 years ago 0

Pharma Law and Business – A Monthly Roundup for January 2013

Not surprisingly, 2013 began with a predictable rush of interesting news. So here are some of the most recent highlights, from court rulings and medical study findings to …
By Ed Silverman
7 years ago 1

Tafas v. Dudas/Doll – 5 Years Later But Still Very Pertinent

Although such Final Rules were widely criticized by most companies in the United States, a sole individual, Dr. Triantafyllos Tafas, a co-inventor of a computerized automated microscope, …

Licensing Executives Society Announces 2010 Deals of Distinction™ Awards

In May 2009, Genzyme Corporation acquired the worldwide rights to a potential breakthrough treatment for Multiple Sclerosis (MS) along with three marketed oncology products from Bayer Healthcare Pharmaceuticals. …
By Gene Quinn
9 years ago 0

Tafas and GlaxoSmithKline Awarded Jefferson Medal by NJIPLA

Tafas and GSK were recognized with this prestigious award for their successful legal challenge to the claims and continuations rules made final in 2007 by the United States …
By Gene Quinn
10 years ago 2

Call to Action: Amici Briefs in ACLU Gene Patent Challenge

Recently I received an e-mail with a link alerting me to something posted on the 271 blog relating to Bilski. The video (viewable on the 271 blog) is taken …
By Gene Quinn
10 years ago 62

JUST IN: Federal Circuit Denies Vacatur in USPTO Rules Case

Earlier today the Chief Judge Paul Michel of the United States Court of Appeals for the Federal Circuit issued an Order declaring the pending appeal of Dr. …
By Gene Quinn
10 years ago 5

GlaxoSmithKline & Tafas Win!!! PTO Loses!!!

In the much anticipated decision from the Eastern District of Virginia the claims and continuation rules enjoined on October 31, 2007, were unceremoniously thrown out!  Judge Cacheris concluded: Because …
By Gene Quinn
12 years ago 0